Drugs / Methyl Prednisolonate
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT04402177 | Jul 2020 → May 2021 | hypersensitivity pneumonitis | Al-Azhar University | Unknown | No outcome recorded |
Also used as a comparator or background therapy in 2 trials
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 01 trial | ||||||
| Phase 0 | NCT04467450 Comparator | Jun → Nov 2020 | bursitis | Benha University | Unknown | No outcome recorded |
| Phase 41 trial | ||||||
| Phase 4 | NCT05103397 Comparator | Oct 2021 → Jan 2022 | — | Ain Shams University | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Methyl Prednisolonate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04402177 ↗ |
| Modality | Small molecule | “steroid group” NCT04467450 ↗ |
| Route | Other | “ultrasound guided injection of Methyl Prednisolonate in the inflamed subacromial subdeltoid bursa” NCT04467450 ↗ |